Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000876874 | SCV001019506 | benign | Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 | 2024-12-16 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003479235 | SCV004223124 | likely benign | not specified | 2023-11-22 | criteria provided, single submitter | clinical testing | Variant summary: TBK1 c.1189+10G>A alters a non-conserved nucleotide located at a position not widely known to affect splicing. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00072 in 232756 control chromosomes. To our knowledge, no occurrence of c.1189+10G>A in individuals affected with Frontotemporal Dementia And/or Amyotrophic Lateral Sclerosis 4 and no experimental evidence demonstrating its impact on protein function have been reported. One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as benign. Based on the evidence outlined above, the variant was classified as likely benign. |
Prevention |
RCV004746121 | SCV005353966 | benign | TBK1-related disorder | 2024-07-05 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |